To date, there have been reports of positive correlations between sclerostin and male gender, age, body mass index (BMI), and T2DM and negative correlations between sclerostin and estrogen replacement, mechanical unloading, and intermittent parathyroid hormone (PTH) therapy [4, 8–12]. Here, PTH is linked to type 2 diabetes mellitus.